Relieving angiotension related hypertension with carboxyalkylacy

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Recombinant or stably-transformed bacterium encoding one or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424273R, 424274, 424313, 424316, 424318, 424319, A61K 31195, A61K 31215, C07C10384

Patent

active

041537254

ABSTRACT:
New carboxyalkylacylamino acids which have the general formula ##STR1## are useful as angiotensin converting enzyme inhibitors.

REFERENCES:
patent: 3462535 (1969-08-01), Loew et al.
patent: 3551419 (1970-12-01), Re et al.
patent: 3852338 (1974-12-01), Kaiser et al.
patent: 3896166 (1975-07-01), Kaiser et al.
Berse et al., J. Org. Chem., vol. 27, 1962, pp. 3489-3495.
Vasilevskii et al., Zh, Org. Khimii, vol. 2, 1970, pp. 244-249.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Relieving angiotension related hypertension with carboxyalkylacy does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Relieving angiotension related hypertension with carboxyalkylacy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relieving angiotension related hypertension with carboxyalkylacy will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1234014

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.